Logo
x

Search

Subscribe Now

Exclusive License

Takeda Signs an Exclusive License Agreement with JCR to Commercialize JR-141 for the Treatment of Hunter Syndrome

Takeda Signs an Exclusive License Agreement with JCR to Commercialize JR-141 for the Treatment of Hunter Syndrome

  • September 30, 2021
ViiV Healthcare Signs an Exclusive License Agreement with Shionogi to Develop S-365598 for HIV

ViiV Healthcare Signs an Exclusive License Agreement with Shionogi to Develop S-365598 for HIV

  • September 28, 2021
AM-Pharma Enters into an Exclusive License Agreement with Kyowa Kirin to Commercialize Ilofotase Alfa in Japan

AM-Pharma Enters into an Exclusive License Agreement with Kyowa Kirin to Commercialize Ilofotase Alfa in Japan

  • September 8, 2021
Dr Reddy's Acquires an Exclusive License for Pregene's PRG1801 in India

Dr Reddy's Acquires an Exclusive License for Pregene's PRG1801 in India

  • May 13, 2021
Henlius Signs an Exclusive License Agreement with Accord for HLX02 (biosimilar- trastuzumab) in the US and Canada

Henlius Signs an Exclusive License Agreement with Accord for HLX02 (biosimilar- trastuzumab) in the US and Canada

  • October 1, 2020
CSPC Pharmaceutical Signs Exclusive License Agreement with Verastem Oncology to Develop and Commercialize Copiktra in China

CSPC Pharmaceutical Signs Exclusive License Agreement with Verastem Oncology to Develop and Commercialize Copiktra in China

  • September 26, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.